Projects funded by the NCN
Evaluation of the activity of MDM2-p53 antagonist RG7388 in mouse cancer models, alone and in combination with anti-PD-1/PD-L1 immunotherapy
2019/35/N/NZ5/03991
Keywords:
RG7388 p53 MDM2 cancer combination therapy cancer immunotherapy
Descriptors:
- NZ5_8: Animal disease treatment
- NZ5_7: Human disease treatment
- NZ3_3: Apoptosis
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Wydział Chemii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 18 - announced on 2019-09-16
Amount awarded: 209 532 PLN
Project start date (Y-m-d): 2020-06-26
Project end date (Y-m-d): 2023-06-25
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.